Patients with nocturnal hypoglycemia level 2 presented longer diabetes duration, lower C peptide, and higher insulin dose than those without hypoglycemia and those with hypoglycemia level 1 (P < 0.05). The gene discussed is INS; the disease is diabetes mellitus.